Overview
Fengzhou Liu practices practicing medicine in Xi'an, China.
Liu is highly rated in 1 condition, according to our data. Their clinical expertise encompasses Cerebral Hypoxia, Secondary Parkinsonism, and Neurotoxicity Syndromes.
They are actively involved in clinical research, co-authoring 13 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Fengzhou Q. Liu
Is Fengzhou Q. Liu a top-rated expert for Cerebral Hypoxia?
MediFind is an objective health platform that identifies experts based on real-world data. Fengzhou Q. Liu is classified as an Advanced expert for Cerebral Hypoxia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Fengzhou Q. Liu participate in research or clinical trials?
Yes. Fengzhou Q. Liu has published 13 articles and abstracts on conditions like Cerebral Hypoxia. You can view a list of Fengzhou Q. Liu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Cerebral HypoxiaLiu isAdvanced. Learn about Cerebral Hypoxia.
- Experienced
- Neurotoxicity SyndromesLiu isExperienced. Learn about Neurotoxicity Syndromes.
- Secondary ParkinsonismLiu isExperienced. Learn about Secondary Parkinsonism.